HIGHLIGHTS
- who: Endotype classification Dupilumab and collaborators from the University of Pennsylvania SmellCenter for Rhinology and Allergology, Wiesbaden, Germany have published the Article: Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP), in the Journal: (JOURNAL)
- what: Analogous to the preceding position papers , the authors provide the following practical recommendations for the use of biologics in CRSwNP based on scientific evidence and the current state of medical knowledge. The aim of this publication is to summarize the current recommendations for the indication and documentation of therapy with biologics in CRSwNP in the German health care system . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.